The Platform of Plasma Protein Users (PLUS) is a consortium of 7 patient organisations representing people living with treatable rare plasma related disorders.
"Increased plasma collection in the EU is a strategic imperative to allow optimal management of patients dependent on plasma-derived medicinal products."
PLUS has released a new consensus statement regarding the #SoHO regulation 👇 https://twitter.com/PlasmaUsers/status/1621116677504270336
PLUS members & stakeholder organisations agreed that #SoHO Regulation is critical to enabling the EU to collect more plasma for the supply of #plasmaderived medicines.
➡️ These key points were identified as important by all stakeholders: https://bit.ly/3jwW8Jz
The Plasma Users Conference ending today brought together patient organisations, Donors, not for profit fractionators and industry. We discussed the proposed SoHO Draft Regulations and a number of important points were collectively agreed. 1/8 @PlasmaUsers
